IDEAYA Biosciences, Inc.
2-oxoquinazoline derivatives as methionine adenosyltransferase 2A inhibitors

Last updated:

Abstract:

Disclosed herein are certain 2-oxoquinazoline derivatives of Formula (IA): ##STR00001## that are methionine adenosyltransferase 2A (MAT2A) inhibitors. Also disclosed are pharmaceutical compositions comprising such compounds and methods of treating diseases treatable by inhibition of MAT2A such as cancer, including cancers characterized by reduced or absence of methylthioadenosine phosphorylase (MTAP) activity.

Status:
Grant
Type:

Utility

Filling date:

12 Feb 2021

Issue date:

29 Jun 2021